Basilea Pharmaceutica AG (OTCMKTS:BPMUF – Get Free Report) shares hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $48.15 and last traded at $48.15, with a volume of 0 shares. The stock had previously closed at $48.15.
Basilea Pharmaceutica Stock Performance
The business’s 50-day moving average price is $47.26 and its 200-day moving average price is $43.25.
About Basilea Pharmaceutica
Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.
Further Reading
- Five stocks we like better than Basilea Pharmaceutica
- Stock Analyst Ratings and Canadian Analyst Ratings
- Sales Breakout Sends This Semiconductor Stock to Record High
- Why is the Ex-Dividend Date Significant to Investors?
- Surprise Buying Opportunity on This Dividend Aristocrat
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- New Theme Park Powerhouse: Merger Creates Industry-Leading Stock
Receive News & Ratings for Basilea Pharmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basilea Pharmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.
